GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gen1E Lifesciences — Funding & Investors." VCBacked, December 23, 2025, https://www.vcbacked.co/company/gen1e-lifesciences. Accessed July 1, 2026.
VCBacked. (2025). Gen1E Lifesciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/gen1e-lifesciences
{{cite web |title=Gen1E Lifesciences — Funding & Investors |url=https://www.vcbacked.co/company/gen1e-lifesciences |website=VCBacked |access-date=July 1, 2026}}Profile data sourced and verified per the VCBacked methodology. Last funding round dated .